Local ablative therapies in hcc: percutaneous ethanol injection and radiofrequency ablation

Digestive Diseases

Volumn 27, Issue 2, 2009, Pages 148-156

  Mahnken, Andreas H ^a,b   Bruners, Philipp ^a,b   Günther, Rolf W ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Hepatocellular carcinoma; Interventional oncology; Percutaneous ethanol injection; Radiofrequency ablation

Indexed keywords

CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOFREQUENCY ABLATION; REVIEW;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; HUMANS; LIVER NEOPLASMS; SOLVENTS;

EID: 67650931601     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218347     Document Type: Review

References (64)

1. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J: Randomized controlled trial of transarterial lipiodol che moembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:11641171.
2. AbouAlfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, De Greve J, Douillard JY, Lathia C, Schwartz B, Taylor I,Moscovici M, Saltz LB: Phase II study of sorafenib in patients with advanced hepato cellular carcinoma. J Clin Oncol 2006;24:42934300.
3. Baccarani U, Benzoni E, Adani GL, Avellini C, Lorenzin D, SainzBarriga M, Bresadola V, Uzzau A, Risaliti A, Beltrami CA, Bresa dola F: Superiority of transplantation versus resection for the treatment of small hepato cellular carcinoma. Transplant Proc 2007;39:18981900.
4. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW: Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22year experience with 467 patients at UCLA. Ann Surg 2007;246:502511.
5. Sharma P, Balan V, Hernandez JL, HarperAM, Edwards EB, RodriguezLuna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH: Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl 2004;10: 3641.
6. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM,Schwartz ME: Longterm results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235:533539.
7. Fong Y, Sun RL, Jarnagin W, Blumgart LH:An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229: 790800.
8. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL,Wong J: Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg 1995;221:291298.
9. Liver Cancer Study Group of Japan: Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277287.
10. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, CraxiA, Cottone M: Transarterial chemoemboli zation for unresectable hepatocellular carcinoma: metaanalysis of randomized controlled trials. Radiology 2002;224:4754.
11. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J; EASL Panel of Experts on HCC: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001;35: 421430.
12. Mor E, Kaspa RT, Sheiner P, Schwartz M:Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129: 643653.
13. Sala M, Llovet JM, Vilana R Bianchi L, Sole M, Ayuso C, Bru C, Bruix J; Barcelona Clinic Liver Cancer Group: Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.Hepatology 2004; 40:13521360.
14. Festi D Monti F, Casanova S, Livraghi T,Frabboni R, Roversi CA, Bertoli D, Borelli G,Mazzella G, Bazzoli F, et al: Morphologicaland biochemical effects of intrahepatic alcohol injection in the rabbit. J GastroenterolHepatol 1990;5:402406.
15. Livraghi T: Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Hepatogastroenterology 1998; 45:12481253.
16. Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA, Boland GW: Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. Am J Roentgenol 1995;164:215220]
17. Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C: Longterm results of singlesession percutaneous ethanol injection in patients with large hepatocellular arcinoma. Cancer 1998; 83: 4857.
18. Goldberg SN, Dupuy DE: Imageguided radiofrequency tumor ablation: challenges and pportunities. Part I. J Vasc Interv Radiol2001;12:10211032.
19. Goldberg SN, Gazelle GS, Mueller PR: Thermal ablation therapy for focal malignancy: aunified approach to underlying principles,techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
20. Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, Isaji S, Shiraki K, Fuke H, Uemoto S, Takeda K: Earlystage hepato cellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008;247:260266.
21. Solbiati L, Tonolini M, Cova L: Monitoring RF ablation. Eur Radiol 2004; 14(suppl 8):P34P42.
22. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M,Schwartz M, Lotze M, Talwalkar J, Gores GJ;Panel of Experts in HCCDesign Clinical Trials: Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698711.
23. Hasegawa S, Yamasaki N, Hiwaki T, Sako K,Komorizono Y, Baba Y, Imamura Y, Kubozo no O, Yoshida A, Arima T: Factors that predict intrahepatic recurrence of hepatocellu lar carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer1999;86:16821690.
24. Livraghi T: Radiofrequency ablation, PEIT,and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003;10:6776.
25. Ebara M, Okabe S, Kita K, Sugiura N, Fu kuda H, Yoshikawa M, Kondo F, Saisho H:Percutaneous ethanol injection for small he patocellular carcinoma: therapeutic efficacybased on 20year observation. J Hepatol 2005; 43:458464.
26. Khan KN, Yatsuhashi H, Yamasaki, Yamasaki M, Inoue O, Koga M, Yano M: Prospective analysis of risk factors for early intrahe patic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol2000;32: 269278.
27. Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, Furuse J, YoshinM, Moriyama N, Sugita M: Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3,225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997;27:251257.
28. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, Chen PJ, Kao JH, Sheu JC, Lee CZ, Chen DS: Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: aprospective study. Ann Surg 2005; 242: 3642.
29. Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA: Significant longterm survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005; 12:616628.
30. Lencioni R, Cioni D, Crocetti L, Franchini C,Pina CD, Lera J, Bartolozzi C: Earlystage he patocellular carcinoma in patients with cirrhosis: longterm results of percutaneous imageguided radiofrequency ablation. Radiology 2005;234:961967.
31. Choi D, Lim HK, Rhim H, Kim YS, Lee WJ,Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC:Percutaneous radiofrequency ablation for earlystage hepatocellular carcinoma as a firstline treatment: longterm results and prognostic factors in a large singleinstitution series. Eur Radiol 2007; 17: 684692.
32. Tateishi R, Shiina S, Teratani T, Obi S, Sato S,Koike Y, Fujishima T, Yoshida H, Kawabe T,Omata: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1,000 cases. Cancer 2005; 103: 12011209.
33. Shiina S, Teratani T, Obi S, Sato S, Tateishi R,Fujishima T, Ishikawa T, Koike Y, Yoshida H,Kawabe T, Omata M: A randomized controlled trial of radiofrequency ablation withethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129: 122130.
34. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC:Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004; 127: 17141723.
35. Akahane M, Koga H, Kato N, Yamada H, Uozumi K, Tateishi R, Teratani T, Shiina S,Ohtomo K: Complications of percutaneous radiofrequency ablation for hepatocellular carcinoma: imaging spectrum and management. Radiographics 2005; 25(suppl 1):S57S68.
36. Brunello F, Veltri A, Crucci P, Pagano E, Cic cone G, Moretto P, Sacchetto P, Gandini G, Rizzetto M: Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 2008; 43:727735.
37. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of he patocellular carcinoma. Hepatology 2005;42:12081236.
38. Livraghi T, Goldberg SN, Lazzaroni S, Melo ni F, Solbiati L, Gazelle GS: Small hepatocel lular carcinoma: treatment with radiofre quency ablation versus ethanol injection. Radiology 1999;210:655661.
39. Lencioni RA, Aligaier HP, Cioni D, Olschews ki M, Deibert P, Crocetti L, Frings H, Lauben berger J, Zuber I, Blum HE, Bartolozzi C: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235240.
40. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pages M, Ayuso C, Sole M, Rodes J, Bruix J; Barcelona Clinic Liver Cancer (BCLC) Group: Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:11241129.
41. Livraghi T, Lazzaroni S, Meloni F, Solbiati L:Risk of tumor seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005;92:856858.
42. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M: Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: metaanalysis of randomized controlled trials. Am J Gastroenterol 2009; 104: 514524.
43. Ohnishi K, Yoshioka H, Ito S, Fujiwara K:Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology1998; 27: 6772.
44. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC:Randomised controlled trial comparing percutaneous radiofrequency thermal ablation,percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:11511156.
45. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS: Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology2000;214: 761768.
46. Cho CM, Tak WY, Kweon YO, Kim SK, ChoiYH, Hwang YJ, Kim YI: The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma (in Korean). Korean JHepatol 2005; 11: 5971.
47. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK,Lee KW, Joh JW: Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and wellpreserved hepatic function. J Clin Gastroenterol 2005; 39: 247252.
48. Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG,Liu GJ, Li DM, Lai JM, Li SQ: Surgical resection versus percutaneous thermal ablation for earlystage hepatocellular carcinoma: arandomized clinical trial (in Chinese). Zhon ghua Yi Xue Za Zhi 2006;86:801805.
49. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V: Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofre quency ablation or resection? HPB (Oxford)2007;9: 429434.
50. Montorsi M, Santambrogio R, Bianchi P, Do nadon M, Moroni E, Spinelli A, Costa M:Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivari ate analysis. J Gastrointest Surg 2005; 9: 6268.
51. Chok KS, Ng KK, Poon RT, Lo CM, Fan ST:Impact of postoperative complications on longterm outcome of curative resection for hepatocellular carcinoma. Br J Surg 2008; 96:8187.
52. Benzoni E, Lorenzin D, Baccarani U, Adani GL, Favero A, Cojutti A, Bresadola F, Uzzau A: Resective surgery for liver tumor: a mul tivariate analysis of causes and risk factors linked to postoperative complications. He patobiliary Pancreat Dis Int 2006; 5: 526533.
53. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L: Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:12061222.
54. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN: Treatment of focal liver tumors with percutaneous radio frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441451.
55. Shetty SK, Rosen MP, Raptopoulos V, Goldberg SN: Costeffectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol 2001;12: 823833.
56. Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, Rodes J, Bruix J: Costeffectiveness of adjuvant therapy for hepato cellular carcinoma during the waiting list for liver transplantation. Gut 2002; 50: 123128.
57. Ikeda K, Kobayashi M, Saitoh S, Someya T,Hosaka T, Sezaki H, Suzuki Y, Suzuki F,Akuta N, Arase Y, Kumada H, Matsuda M,Hashimoto M, Watanabe G: Costeffective ness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3 cm or less in diameter. Hepatol Res 2005; 33:241249.
58. Luo BM, Wen YL, Yang HY, Zhi H, Xiao XY,Ou B, Pan JS, Ma JH: Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carc noma. World J Gastroenterol 2005; 11: 62776280.
59. Koda M, Murawaki Y, Mitsuda A, Oyama K,Okamoto K, Idobe Y, Suou T, Kawasaki H:Combination therapy with transcatheter arterial chemoembolization and percutaneous thanol injection compared with percutaneous ethanol injection alone for patients with mall hepatocellular carcinoma: a randomized control study. Cancer 2001; 92: 15161524.
60. Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Dux M, Kauffmann GW: Longterm results of interventional treatment of large unresectable hepatocellular carcinoma: significant survival benefit from combined transcatheter arterial chemoembolization and percutaneous ethanol injection compared to TACE monotherapy. Rofo 2004; 176:17941802.
61. Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, Fong Y, Jarna gin W, D'Angelica M, Blumgart L, DeMatteo R, Brown KT: Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 2005;16:955961.
62. Vivarelli M, Guglielmi A, Ruzzenente A,Cucchetti A, Bellusci R, Cordiano C, Cavallari A: Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004;240:102107.
63. Ogihara M, Wong LL, Machi J: Radiofre quency ablation versus surgical resection for single nodule hepatocellular carcinoma: longterm outcomes. HPB (Oxford) 2005; 7:214221.
64. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatecto my for small hepatocellular carcinoma. Ann Surg 2006;243:321328.